x
Breaking News
0

Mylan Inc (MYL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mylan's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
38.44 +0.26    +0.68%
18:29:59 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: NL0011031208 
CUSIP: 001103120
  • Volume: 2,068,441
  • Bid/Ask: 38.43 / 38.44
  • Day's Range: 38.01 - 38.44
Start Trading with Nadex
Mylan 38.44 +0.26 +0.68%

MYL Overview

 
Information about the Mylan Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close38.18
Day's Range38.01 - 38.44
Revenue12.01B
Open38.03
52 wk Range29.39 - 45.87
EPS1.23
Volume2,068,441
Market Cap20.48B
Dividend (Yield)0 (N/A)
Average Vol. (3m)6,275,797
P/E Ratio31.13
Beta1.37
1-Year Change4.63%
Shares Outstanding536,280,738
Next Earnings DateNov 07, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Strong Sell Neutral Buy Buy
Technical Indicators Strong Sell Sell Sell Strong Buy Strong Sell
Summary Strong Sell Strong Sell Neutral Strong Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Deliberation Bearish 15 Current
Completed Patterns
Bullish doji Star 1M 1 Sep 17
Bullish Engulfing 5H 5 Oct 13, 2017 08:00AM
Dark Cloud Cover 1M 7 Mar 17

Mylan Inc News & Analysis

Mylan Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 38.44 38.43 38.44 2,068,441 +0.68% USD 18:29:59  
  Berlin 32.270 32.380 32.480 0 +0.58% EUR 06:08:00  
  Stuttgart 32.378 32.379 32.484 150 +0.46% EUR 16:28:00  
  Munich 32.150 0.000 0.000 0 -1.08% EUR 06:01:00  
  Tel Aviv 13,400 13,400 13,420 312,698 +0.75% ILS 14:24:00  
  Vienna 32.330 0.000 0.000 0 0.00% EUR 16/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 160.22 160.87 159.23 +0.34 +0.21% 14.34M 18:29:58  
  Netflix 199.05 204.38 197.77 -3.63 -1.79% 20.65M 18:29:52  
  Tesla 353.90 356.22 350.07 +3.30 +0.94% 2.47M 18:29:59  
  Neothetics Inc 1.71 1.78 0.83 +1.19 +228.97% 47.00M 18:29:58  
  Facebook 175.34 175.96 174.36 +0.82 +0.47% 11.55M 18:29:59  
  NVIDIA 197.10 198.90 196.35 -0.83 -0.42% 9.44M 18:29:54  
  Amazon.com 1,005.32 1,011.47 1,004.39 -1.02 -0.10% 1.63M 18:29:52  
  Goldman Sachs 236.00 244.70 235.56 -6.41 -2.64% 5.38M 18:29:55  
  J&J 140.63 141.12 137.06 +4.51 +3.31% 7.24M 18:29:56  
  Transenterix Inc 4.1560 5.0000 3.2800 +1.3460 +47.90% 123.54M 18:29:41  

Mylan Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

35000

Equity Type

ORD

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) Start Trading

My Sentiments

What is your sentiment on Mylan?
or
Vote to see community's results!

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Mylan Inc
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest MYL Comments

João Félix
João Félix Sep 29, 2017 7:42AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mylan shareholders vote against executive pay. .Directors face strong opposition. .These group of Directors don't have the profile and competency to manage Mylan at this moment in time. That is the main problem of this company.
Reply
0 0
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
 
 
 
Add Chart to Comment
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email